Emerging Therapy

Dave Bloom - 2017/02/01

Another food allergy therapy showing early promise.

Dave Bloom - 2017/01/12

Proof-of-concept study is the first step in bringing the treatment to market.

Dave Bloom - 2016/10/27

The treatment reduced the observed symptoms of anaphylaxis and lowered other key protein markers by up to 90% in mice.

Dave Bloom - 2016/10/25

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Dave Bloom - 2016/10/14

A researcher from Nova Southeastern University is working on a novel way to deliver epinephrine.

Dave Bloom - 2016/09/29

"There’s a clear path to a marketable product here that could have tremendous impact globally."

Dave Bloom - 2016/09/13

The economies of scale of the device's multiple applications could potentially result in a lower cost alternative for epinephrine delivery.

Dave Bloom - 2016/09/07

MannKind Corporation is developing a product that would dispose of the needle entirely.

Dave Bloom - 2016/08/29

Here are articles we published in the past year on four noteworthy auto-injector designs currently at various stages in the pipeline.

Dave Bloom - 2016/08/11

"The first-ever clinical study of preschoolers allergic to peanuts could lead to safe and effective treatment for millions of people."